Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06734286

Working Memory Training in Patients with Mild Cognitive Impairment

CogMed Intervention Targeting Working Memory in Patients with Mild Cognitive Impairment

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
St. Joseph's Hospital and Medical Center, Phoenix · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to test whether a special memory training program, called CogMed, can help people with early memory problems. The Investigators want to see if this training improves memory and also helps reduce stress. The Investigators also want to see if CogMed results in changes to a blood biomarker called p-Tau 217, which possibly indicate Alzheimer's disease (AD).

Detailed description

The goal of this study is to conduct a pilot clinical trial aimed at comparing the effects of CogMed intervention plus Treatment As Usual (TAU) versus TAU alone in patients with Mild Cognitive Impairment (MCI). Based on our preliminary data from brain health program, the primary hypothesis is that the CogMed intervention may improve the CogMed measures and possibly working memory. This may improve sense of self-efficacy and lead to a decrease in perceived stress, thereby demonstrating possible transfer of cognitive benefits to biobehavioral construct of perceived stress. Additionally, the study aims to demonstrate the feasibility of collecting p-Tau 217, a blood based Alzheimer's Disease biomarker, from MCI patients. Though no significant changes in pTau 217 are expected due to the short duration of the study, the goal is to successfully recruit 10 MCI patients (5 in the intervention group and 5 in the control group) who are willing to undergo blood draws for p-Tau 217 level determination.

Conditions

Interventions

TypeNameDescription
OTHERCogMedCogMed which is a computerized working memory training program developed by Karolinska University.

Timeline

Start date
2024-09-16
Primary completion
2025-06-30
Completion
2025-09-30
First posted
2024-12-16
Last updated
2024-12-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06734286. Inclusion in this directory is not an endorsement.